diabetes glp-1 vs sglt2 inhibitors or receptor agonists as second-line therapy in | VHRM Hypoglycemia Risk With SGLT2 Inhibitors
Description
The problem is that this would be significantly expensive for the states
Many even see reduced inflammation
Visceral fat produces inflammatory markers that increase cardiovascular disease risk
Dehydration: Alcohol makes the body lose more fluids, which can make you feel more lightheaded or dizzy
One drawback: It's relatively high in sodium and saturated fat
